Guardant Health, Inc. (GH)
161.10
-1.96
(-1.20%)
USD |
NASDAQ |
Sep 03, 16:00
161.10
0.00 (0.00%)
After-Hours: 18:22
Guardant Health Cash from Investing (Quarterly) : 101.47M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 101.47M |
| March 31, 2026 | 699.42M |
| December 31, 2025 | -905.07M |
| September 30, 2025 | -14.35M |
| June 30, 2025 | -10.65M |
| March 31, 2025 | 302.86M |
| December 31, 2024 | 10.53M |
| September 30, 2024 | -294.83M |
| June 30, 2024 | -5.077M |
| March 31, 2024 | 28.07M |
| December 31, 2023 | 663.45M |
| September 30, 2023 | 260.70M |
| June 30, 2023 | -241.13M |
| March 31, 2023 | 157.22M |
| December 31, 2022 | 70.63M |
| September 30, 2022 | 41.27M |
| Date | Value |
|---|---|
| June 30, 2022 | -72.89M |
| March 31, 2022 | 110.81M |
| December 31, 2021 | -266.70M |
| September 30, 2021 | -47.39M |
| June 30, 2021 | 127.07M |
| March 31, 2021 | 123.87M |
| December 31, 2020 | -297.68M |
| September 30, 2020 | -14.66M |
| June 30, 2020 | -325.55M |
| March 31, 2020 | 20.80M |
| December 31, 2019 | 23.36M |
| September 30, 2019 | -35.73M |
| June 30, 2019 | -320.53M |
| March 31, 2019 | 15.33M |
| December 31, 2018 | -197.69M |
| September 30, 2018 | 65.46M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Natera, Inc. | -63.43M |
| NeoGenomics, Inc. | -8.319M |
| Quest Diagnostics, Inc. | -134.00M |
| Labcorp Holdings, Inc. | -366.20M |
| OPKO Health, Inc. | 15.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -57.78M |
| Cash from Financing (Quarterly) | 23.01M |
| Free Cash Flow | -228.54M |
| Free Cash Flow Per Share (Quarterly) | -0.5234 |
| Free Cash Flow to Equity (Quarterly) | -61.99M |
| Free Cash Flow to Firm (Quarterly) | -68.19M |
| Free Cash Flow Yield | -1.10% |